We are pleased to advise that our first site in China, Beijing Chaoyang Hospital, has commenced patient recruitment! All patients diagnosed with multiple myeloma or a related diseases from this hospital will be invited to participate in the registry.

Beijing Chaoyang Hospital is one of three Chinese hospitals confirmed to participate in the APAC MRDR. We are grateful for the efforts of the research team, and look forward to seeing the results of the study at this hospital and more broadly in China.